1. [1] Azizi F, Hatami H, Jonghorbani M. [Epidemiology and control disease in Iran (Persian)]. Tehran: Eshtiagh Publication; 2000. http://opac.nlai.ir/opac-prod/bibliographic/617745
2. [2] Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 countryyears and 5ยท4 million participants. Lancet. 2011; 377(9765):568-77. [DOI:10.1016/S0140-6736(10)62036-3] [
DOI:10.1016/S0140-6736(10)62036-3]
3. [3] World Health Organization. The World Health report: 2002: Reducing risks, promoting healthy life [Internet]. 2002 [Updated 2002]. Available from: https://apps.who.int/iris/handle/10665/67454
4. [4] Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1):1-39.e14. [DOI:10.1016/j.echo.2014.10.003] [PMID] [
DOI:10.1016/j.echo.2014.10.003]
5. [5] Azizi F. [Prevening NCDS: Improving lifestyle an inevitable necessity (Persian)]. Pejouhesh dar Pezeshki (Res Med). 2003; 27(4):261-3. https://pejouhesh.sbmu.ac.ir/browse.php?a_id=64&sid=1&slc_lang=fa
6. [6] World Health Organization. Global status report on noncommunicable diseases 2014 [Internet]. 2014 [Updated 2014]. Available from: https://apps.who.int/iris/handle/10665/148114
7. [7] Azizi A, Abasi MR, Abdoli GR. [The prevalence of hypertension and its association with age, sex and BMI in a population being educated using community-based medicine in Kermanshah: 2003 (Persian)]. Iran J Endocrinol Metab. 2008; 10(4):323-9. http://ijem.sbmu.ac.ir/article-1-578-en.html
8. [8] Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360(9343):1347-60. [DOI:10.1016/S0140-6736(02)11403-6] [PMID] [
DOI:10.1016/S0140-6736(02)11403-6]
9. [9] World Health Organization. WHO Package of Essential NCD Interventions (WHO PEN) for primary care in low-resource settings: Essential technologies and medicines and risk prediction tools. In: World Health Organization. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low Resource Settings. Geneva: World Health Organization; 2010. pp. 35-42. https://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf
10. [10] Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risfactors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012; 12:117 [DOI:10.1186/1471-2377-12-117] [PMID] [PMCID] [
DOI:10.1186/1471-2377-12-117]
11. [11] Lotfaliany M, Akbarpour S, Mozafary AH, Rajab Boloukat R, Azizi F, Hadaegh F. Hypertension phenotypes and incident cardiovascular disease and mortality events in a decade followup of a Middle East cohort. J Hypertens. 2015; 33(6):1153-61. [DOI:10.1097/HJH.0000000000000540] [PMID] [
DOI:10.1097/HJH.0000000000000540]
12. [12] Khalili D, Haj Sheikholeslami F, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: A 10-year population-based cohort study. PloS One. 2014;9(8):e105804 [DOI:10.1371/journal.pone.0105804] [PMID] [PMCID] [
DOI:10.1371/journal.pone.0105804]
13. [13] Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens. 2013; 31(7):1364-71. [DOI:10.1097/HJH.0b013e3283613053] [PMID] [PMCID] [
DOI:10.1097/HJH.0b013e3283613053]
14. [14] Mohsenzadeh Y, Motedayen M, Hemmati F, Sayehmiri K, Sarokhani MT, Sarokhani D. Investigating the prevalence rate of hypertension in Iranian men and women: A study of systematic review and meta-analysis. J Basic Res Med Sci. 2017;4(1):53-62. [DOI:10.18869/acadpub.jbrms.4.1.53] [
DOI:10.18869/acadpub.jbrms.4.1.53]
15. [15] Eghbali M, Khosravi AR, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: A crosssectional study in Iran. Epidemiol Health. 2018; 40:e2018020. [DOI:10.4178/epih.e2018020] [PMID] [PMCID] [
DOI:10.4178/epih.e2018020]
16. [16] Afsargharehbagh R, Rezaie-Keikhaie Kh, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: A meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019; 21(4):27. [DOI:10.1007/s11906-019-0933-z] [PMID] [
DOI:10.1007/s11906-019-0933-z]
17. [17] Jafari Oori M, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Ghanei Gheshlagh R. Prevalence of HTN in Iran: Meta-analysis of published studies in 2004-2018. Curr Hypertens Rev. 2019; 15(2):113-22. [DOI:10.2174/1573402115666190118142818] [PMID] [PMCID] [
DOI:10.2174/1573402115666190118142818]
18. [18] Esteghamati AR, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie AP, Khajeh E, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. Arch Iran Med. 2016; 19(7):456-64. [PMID]
19. [19] Aghamolaei T, Hossaini FS, Farshidi H, Madani A, Ghanbarnejad A. [Lifestyle of patients with high blood pressure in rural areas of Jahrom, Iran (Persian)]. J Prev Med. 2014; 1(1):1-9. http://jpm.hums.ac.ir/article-1-35-en.html
20. [20] Mostafavi H, Zare N, Dabghmanesh MH. [Blood pressure levels, risk factors and hypertension control status in adult population of Shiraz (Persian)]. Hormozgan Med J. 2007;11(1):43-51. https://hmj.hums.ac.ir/Article/89106
21. [21] Ahangari T, Masudi S, Salarilak Sh. [Mortality attributable to high blood pressure for cardiovascular diseases in the West Azerbaijan province 25-64 years old population (Persian)]. Med J Tabriz Univ Med Sci. 2019; 40(6):7-13. https://mj.tbzmed.ac.ir/Article/23990